[go: up one dir, main page]

SI0849990T1 - Quiescent cell populations for nuclear transfer - Google Patents

Quiescent cell populations for nuclear transfer

Info

Publication number
SI0849990T1
SI0849990T1 SI9630282T SI9630282T SI0849990T1 SI 0849990 T1 SI0849990 T1 SI 0849990T1 SI 9630282 T SI9630282 T SI 9630282T SI 9630282 T SI9630282 T SI 9630282T SI 0849990 T1 SI0849990 T1 SI 0849990T1
Authority
SI
Slovenia
Prior art keywords
nuclear transfer
cell populations
quiescent cell
quiescent
cell
Prior art date
Application number
SI9630282T
Other languages
English (en)
Inventor
Keith Henry Stockman Campbell
Ian Wilmut
Original Assignee
Roslin Inst Edinburgh
Mini Agriculture & Fisheries
Biotech & Biolog Scien Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roslin Inst Edinburgh, Mini Agriculture & Fisheries, Biotech & Biolog Scien Res filed Critical Roslin Inst Edinburgh
Publication of SI0849990T1 publication Critical patent/SI0849990T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8771—Bovine embryos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8773—Ovine embryos

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Environmental Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
SI9630282T 1995-08-31 1996-08-30 Quiescent cell populations for nuclear transfer SI0849990T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9517780.4A GB9517780D0 (en) 1995-08-31 1995-08-31 Biological manipulation
PCT/GB1996/002099 WO1997007669A1 (fr) 1995-08-31 1996-08-30 Populations de cellules quiescentes pour transfert de noyau
EP96928587A EP0849990B1 (fr) 1995-08-31 1996-08-30 Populations de cellules quiescentes pour transfert de noyau

Publications (1)

Publication Number Publication Date
SI0849990T1 true SI0849990T1 (en) 2001-06-30

Family

ID=10779998

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630282T SI0849990T1 (en) 1995-08-31 1996-08-30 Quiescent cell populations for nuclear transfer

Country Status (23)

Country Link
US (5) US6147276A (fr)
EP (3) EP0849990B1 (fr)
JP (2) JP4081613B2 (fr)
KR (4) KR20070047848A (fr)
CN (3) CN1769431A (fr)
AT (1) ATE199115T1 (fr)
AU (1) AU716956C (fr)
BR (1) BR9610034B1 (fr)
CA (1) CA2229568C (fr)
CZ (1) CZ60898A3 (fr)
DE (1) DE69611793T2 (fr)
DK (1) DK0849990T3 (fr)
ES (1) ES2155197T3 (fr)
GB (2) GB9517780D0 (fr)
HU (1) HUP9900234A3 (fr)
IL (1) IL123298A0 (fr)
NO (1) NO980845L (fr)
NZ (3) NZ337311A (fr)
PL (1) PL325331A1 (fr)
SG (1) SG75155A1 (fr)
SI (1) SI0849990T1 (fr)
WO (1) WO1997007669A1 (fr)
ZA (1) ZA967390B (fr)

Families Citing this family (228)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5480772A (en) 1993-02-03 1996-01-02 Brandeis University In vitro activation of a nucleus
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US7307198B2 (en) 1995-08-31 2007-12-11 Roslin Institute Ungulates produced by nuclear transfer of G1 cells
US6077697A (en) * 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6025155A (en) * 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US7696404B2 (en) 1996-08-19 2010-04-13 Advanced Cell Technology, Inc. Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
JP2002511732A (ja) 1996-10-11 2002-04-16 ザ・テキサス・エイ・アンド・エム・ユニヴァーシティ・システム トランスジェニック動物を発生させるための組成物および方法
US6215041B1 (en) * 1997-01-10 2001-04-10 University Of Mmassachusetts Cloning using donor nuclei from a non-quiesecent somatic cells
US6235969B1 (en) * 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US20090092588A1 (en) * 1997-01-10 2009-04-09 University Of Massachusetts As Represented By Its Amherst Campus Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease
GB9703550D0 (en) * 1997-02-20 1997-04-09 Ppl Therapeutics Scotland Ltd Cell mediated transgenesis
US6011197A (en) 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
WO1998048005A1 (fr) 1997-04-24 1998-10-29 University Of Washington Modification genetique ciblee au moyen de vecteurs parvoviraux
WO1998057984A2 (fr) 1997-06-19 1998-12-23 The General Hospital Corporation Torsine, genes de torsine et leurs utilisations
US6921814B2 (en) 1997-06-19 2005-07-26 The General Hospital Corporation Torsin, torsin-related genes and methods of detecting neuronal disease
EP1017422A4 (fr) * 1997-07-03 2002-10-29 Univ Massachusetts Clonage a l'aide de noyaux donneurs a partir de cellules differentiees ne presentant pas de carence serique
AU8587598A (en) * 1997-07-26 1999-02-16 Wisconsin Alumni Research Foundation Trans-species nuclear transfer
AU8817798A (en) * 1997-08-22 1999-03-16 Biotechnology And Biological Sciences Research Council, The Use of (mariner) transposan in the production of transgenic animals
AU732996C (en) * 1997-09-02 2001-12-06 Cancer Research Campaign Technology Limited A cell-free replication system and uses thereof
AU1581899A (en) * 1997-10-28 1999-05-17 Biotransplant Incorporated Nuclear transfer for production of transgenic animal embryo
US6600087B1 (en) 1998-01-16 2003-07-29 Agrobiogen Gmbh Efficient nuclear transfer using fetal fibroblasts and multiple cloning procedures
US6331659B1 (en) 1998-01-21 2001-12-18 University Of Hawaii Cumulus cells as nuclear donors
JP2002511234A (ja) * 1998-03-16 2002-04-16 リレグ ピーティーワイ リミテッド ブタの核移植
AUPP294898A0 (en) * 1998-04-15 1998-05-07 Monash University Method of nuclear transfer
GB9808325D0 (en) * 1998-04-20 1998-06-17 Ltr Ciz Di Associazione Italia Source of nuclei for nuclear transfer
GB9809178D0 (en) * 1998-04-29 1998-07-01 Univ Edinburgh Nuclear reprogramming of somatic cells
AU6218899A (en) 1998-10-12 2000-05-01 Geron Bio-Med Limited Porcine oocytes with improved developmental competence
AU2003204830B2 (en) * 1998-11-02 2007-08-30 Gtc Biotherapeutics, Inc. Transgenic and cloned mammals
EP1375654A3 (fr) * 1998-11-02 2008-01-16 GTC Biotherapeutics, Inc. Mammifères trangéniques et clonés
EP1127113A2 (fr) * 1998-11-02 2001-08-29 Genzyme Transgenics Corporation Mammiferes transgeniques et clones
US6781030B1 (en) 1998-11-02 2004-08-24 Trustee Of Tufts College, Ballou Hall Methods for cloning mammals using telophase oocytes
US6580017B1 (en) 1998-11-02 2003-06-17 Genzyme Transgenics Corporation Methods of reconstructed goat embryo transfer
EP1130961B1 (fr) 1998-11-19 2009-04-08 Pharming Intellectual Property BV Stabilisation du lait provenant d'animaux transgeniques
US6258998B1 (en) 1998-11-24 2001-07-10 Infigen, Inc. Method of cloning porcine animals
US6700037B2 (en) 1998-11-24 2004-03-02 Infigen, Inc. Method of cloning porcine animals
EP1141265B1 (fr) * 1999-01-13 2008-09-03 Revivicor, Inc. Procede de double transfert de noyau et resultats de ce transfert
GB9903804D0 (en) * 1999-02-20 1999-04-14 Univ Sheffield Pluripotential cells-2
GB9903805D0 (en) * 1999-02-20 1999-04-14 Univ Sheffield Pluripotential cells-1
WO2000050443A2 (fr) 1999-02-26 2000-08-31 Millennium Pharmaceutcals, Inc. Proteines secretees et leurs utilisations
JP2002537785A (ja) * 1999-03-04 2002-11-12 ピーピーエル セラピューティクス （スコットランド） リミテッド 体細胞の遺伝的改変とそれらの使用
US20020012660A1 (en) * 1999-03-04 2002-01-31 Alan Colman Method of preparing a somatic cells for nuclear transfer
BR0010588A (pt) * 1999-04-28 2003-07-22 Univ Montreal Oócitos enucleados de telofase para transferência nuclear
DE69934914T2 (de) * 1999-06-04 2007-10-18 Istituto Zootecnico E Caseario Per La Sardegna Verfahren zur rekonstruktion eines nicht-menschlichen tierischen embryos mittels kerntransfer und die herstellung des tieres daraus.
WO2001000855A1 (fr) 1999-06-23 2001-01-04 Ppl Therapeutics (Scotland) Ltd. Proteines de fusion incorporant un lysozyme
EP1196426A4 (fr) 1999-06-30 2003-09-03 Advanced Cell Tech Inc Transfert cytoplasmique permettant de reduire la differentiation de cellules receveuses
CN1304445A (zh) * 1999-06-30 2001-07-18 黄禹锡 一种通过用种间核转移技术生产克隆虎的方法
US7291714B1 (en) 1999-06-30 2007-11-06 Millennium Pharmaceuticals, Inc. Glycoprotein VI and uses thereof
AU753207B2 (en) 1999-06-30 2002-10-10 Seoul National University Industry Foundation Method for producing cloned cows
CA2334953A1 (fr) * 1999-06-30 2001-01-04 Woo-Suk Hwang Procede d'obtention d'embryons humains clones au moyen de techniques de transplantation inter-especes de noyaux
DK1210428T3 (en) 1999-08-23 2015-06-15 Dana Farber Cancer Inst Inc PD-1, a receptor for B7-4 AND USE THEREOF
WO2002064799A2 (fr) 1999-09-28 2002-08-22 Transkaryotic Therapies, Inc. Arn messager optimise
EP2275559A3 (fr) 1999-09-28 2011-03-23 Shire Human Genetic Therapies, Inc. ARN messager (ARN-m) optimisé
KR20020038776A (ko) * 1999-09-30 2002-05-23 추후보정 클로닝된 트랜스게닉 포유동물의 제조 방법
KR100417566B1 (ko) * 1999-11-19 2004-02-05 한국생명공학연구원 체세포 핵치환 복제수정란의 대량생산방법
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
WO2001035735A1 (fr) * 1999-11-19 2001-05-25 Hematech, Llc Production d'ongules, de preference des bovins, qui produisent des immunoglobulines humaines
US7820878B2 (en) * 1999-11-19 2010-10-26 Kyowa Hakko Kirin Co., Ltd. Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
US6635802B1 (en) * 2000-01-10 2003-10-21 The Texas A&M University System Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
GB0001401D0 (en) * 2000-01-22 2000-03-08 Univ Edinburgh Methods for amplifying genetic material and use thereof
EP1356031B1 (fr) 2000-03-15 2011-07-27 The University Of Georgia Research Foundation, Inc. Reprogrammation effective de materiel nucleaire chez des mammiferes
US20040033600A1 (en) 2001-03-21 2004-02-19 Palli Subba Reddy Ecdysone receptor-based inducible gene expression system
GB2360522A (en) 2000-03-24 2001-09-26 Geron Corp A strategy for maintaining pregnancy
AU2001261650A1 (en) * 2000-05-15 2001-11-26 Geron Corporation Ovine tissue for xenotransplantation
ATE439453T1 (de) 2000-06-05 2009-08-15 Genetics Inst Llc Zusammensetzungen, testsätze und methoden zur identifizierung und modulation von typ i diabetes
AU7309601A (en) 2000-06-28 2002-01-08 Genetics Inst Pd-l2 molecules: novel pd-1 ligands and uses therefor
WO2002009510A2 (fr) * 2000-08-01 2002-02-07 Xy Genetics, Llc Procedes de selection et de clonage
EP1311530A4 (fr) 2000-08-03 2004-10-06 Wim-Van Schooten Production d'anticorps humanises dans des animaux transgeniques
AU2001284948A1 (en) 2000-08-15 2002-02-25 Board Of Trustees Of The University Of Illinois Animals expressing exogenous igf-i in their milk
WO2002019811A2 (fr) * 2000-09-06 2002-03-14 Nexia Biotechnologies, Inc. Production d'animaux transgeniques par transfert nucleaire et par emploi d'oocytes au stade de vesicule germinative
US20040029825A1 (en) * 2001-10-03 2004-02-12 Davies Christopher J Methods of minimizing immunological rejection of a nuclear transfer fetus
US8105825B2 (en) * 2000-10-03 2012-01-31 Intrexon Corporation Multiple inducible gene regulation system
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US7037652B2 (en) 2000-11-28 2006-05-02 Wyeth Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
IL155952A0 (en) 2000-11-28 2003-12-23 Wyeth Corp Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
DE60044301D1 (de) 2000-12-22 2010-06-10 Agronomique Inst Nat Rech Positionsunabhängige und gewebespezifische Expression eines Transgens in der Milch eines Transgen-Tieres
NZ525607A (en) 2000-12-22 2005-05-27 Aurox Llc Methods for cloning mammals using reprogrammed donor chromatin or donor cells
US7491534B2 (en) 2000-12-22 2009-02-17 Kirin Holdings Kabushiki Kaisha Methods for altering cell fate to generate T-cells specific for an antigen of interest
US20020142397A1 (en) 2000-12-22 2002-10-03 Philippe Collas Methods for altering cell fate
EP1860199B1 (fr) 2001-01-12 2014-03-05 Exelixis, Inc. Modulation de signal de récépteur d'insuline
WO2002074078A2 (fr) 2001-01-30 2002-09-26 Rebholtz, Amy, K. Systemes de transfert d'embryons et de gestion de receveurs
AU2002250020A1 (en) * 2001-02-02 2002-08-19 Erik Forsberg Method of cloning transgenic mammalian animals using pseudonuclei
CA2438119C (fr) * 2001-02-20 2014-12-16 Rheogene Holdings, Inc. Recepteurs x de retinoides chimeriques et utilisations de ceux-ci dans un nouveau systeme d'expression de gene inductible fonde sur un recepteur d'ecdysone
US7309811B2 (en) 2001-02-23 2007-12-18 Elan Pharmaceuticals, Inc Transgenic mice knockouts of BACE-1
JP2002262716A (ja) * 2001-03-07 2002-09-17 National Agricultural Research Organization 株化細胞を用いて家畜個体を作出する方法
AU2002258477A1 (en) * 2001-03-08 2002-09-24 Advanced Cell Technology, Inc. Use of rna interference for the creation of lineage specific es and other undifferentiated cells and production of differentiated cells in vitro by co-culture
AUPR363701A0 (en) 2001-03-09 2001-04-05 Garelag Pty Ltd Method for the production of nuclear transfer embryos
US8981061B2 (en) 2001-03-20 2015-03-17 Novo Nordisk A/S Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
WO2002074935A2 (fr) * 2001-03-21 2002-09-26 Geron Corporation Utilisation de la transcriptase inverse de la telomerase dans la creation d'animaux knockout homozygotes
US7126039B2 (en) * 2001-03-21 2006-10-24 Geron Corporation Animal tissue with carbohydrate antigens compatible for human transplantation
WO2002078449A2 (fr) * 2001-04-02 2002-10-10 Advanced Cell Technology, Inc. Procede permettant de faciliter la production de types de cellules et de tissus differencies a partir de cellules pluripotentes et multipotentes embryonnaires et adultes
MXPA03008959A (es) 2001-04-02 2004-10-15 Wyeth Corp Pd-1, un receptor para b7-4 y sus usos.
EP1572868A4 (fr) 2001-04-16 2007-04-04 Wyeth Corp Nouveaux cadres de lecture ouverts de streptococcus pneumoniae codant pour des antigenes polypeptidiques, et leurs utilisations
WO2002092791A1 (fr) * 2001-05-14 2002-11-21 Stell Tissus ou organes utilises dans la xenotransplantation
US20030153044A1 (en) * 2001-05-14 2003-08-14 Monika Liljedahl Tissues or organs for use in xenotransplantation
AU2002326353A1 (en) * 2001-07-09 2003-01-29 Alexion Pharmaceuticals Inc. Cloned non-human mammals from contact inhibited donor cells
EP1900815B1 (fr) 2001-07-12 2016-09-07 University of Massachusetts Production in vivo de petits ARN interférents qui modèrent le silençage génique
WO2003006477A1 (fr) 2001-07-12 2003-01-23 University Of Massachusetts Production in vivo of small interfering rnas that mediate gene silencing
WO2003011016A2 (fr) * 2001-07-31 2003-02-13 Stell Vaches genetiquement modifiees presentant une vulnerabilite reduite a la maladie de la vache folle
US20030211603A1 (en) * 2001-08-14 2003-11-13 Earp David J. Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
JP2005514921A (ja) 2001-11-09 2005-05-26 ダナ−ファーバー キャンサー インスティチュート インク ＰＧＣ−１β、新規ＰＧＣ−１相同体およびその用途
US20050170506A1 (en) * 2002-01-16 2005-08-04 Primegen Biotech Llc Therapeutic reprogramming, hybrid stem cells and maturation
US20050090004A1 (en) * 2003-01-16 2005-04-28 Sayre Chauncey B. Stem cell maturation for all tissue lines
US20030134422A1 (en) * 2002-01-16 2003-07-17 Sayre Chauncey Bigelow Stem cell maturation for all tissue lines
BRPI0307383B1 (pt) * 2002-01-23 2019-12-31 The Univ Of Utah Research Foundation método de recombinação genética direcionada em célula de planta hospedeira
KR100502695B1 (ko) * 2002-02-28 2005-07-25 한국생명공학연구원 형질전환 효율이 향상된 복제수정란의 대량 생산 방법
EP1504092B2 (fr) * 2002-03-21 2014-06-25 Sangamo BioSciences, Inc. Procedes et compositions permettant d'utiliser des endonucleases a doigts de zinc pour ameliorer la recombinaison homologue
GB0207299D0 (en) * 2002-03-28 2002-05-08 Franks Christopher R Stem cell therapy
CA2480802A1 (fr) * 2002-04-01 2003-10-16 Gtc Biotherapeutics, Inc. Procede permettant la selection de lignees cellulaires convenant pour le transfert de noyau chez les especes mammiferes
US20030207448A1 (en) * 2002-05-06 2003-11-06 Revera Gregory Henry Methodologies for the creation of pluripotent or multipotent human stem cells without creating or destroying a human embryo
GB0211904D0 (en) * 2002-05-23 2002-07-03 Medical Res Council Nuclear transfer
US7410797B2 (en) * 2002-06-11 2008-08-12 Ogle Roy C Meningeal-derived stem cells
US7612250B2 (en) * 2002-07-29 2009-11-03 Trustees Of Tufts College Nuclear transfer embryo formation method
WO2004018999A2 (fr) 2002-08-20 2004-03-04 Millenium Pharmaceuticals, Inc. Compositions, kits, et procedes d'identification, d'evaluation, de prevention et de therapie de cancer du col
AU2003298574B2 (en) 2002-09-05 2008-04-24 California Institute Of Technology Use of chimeric nucleases to stimulate gene targeting
AU2003300027A1 (en) 2002-10-10 2004-05-04 Wyeth Compositions, organisms and methodologies employing a novel human kinase
US20040077077A1 (en) * 2002-10-18 2004-04-22 Xiangzhong Yang Novel methods for the production of cloned mammals, mammals cloned according to the methods, and methods of use of same
EP1554385A2 (fr) 2002-10-24 2005-07-20 Wyeth Compositions, organismes et procedes faisant appel a une nouvelle proteine phosphatase humaine
AU2003290689A1 (en) 2002-11-08 2004-06-03 Kyowa Hakko Kirin Co., Ltd. Transgenic ungulates having reduced prion protein activity and uses thereof
JP2006514554A (ja) 2002-11-21 2006-05-11 ワイス 腎細胞癌および他の固形腫瘍の診断法
AU2003290664A1 (en) 2002-11-27 2004-06-23 Wei Liu Compositions, organisms and methodologies employing a novel human kinase
JP2006508676A (ja) * 2002-12-10 2006-03-16 ジーティーシー バイオセラピューティックス インコーポレイテッド 追加の核移植のための細胞ドナーとして体細胞核移植胚を利用する方法および系
US7482117B2 (en) 2002-12-20 2009-01-27 Celera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
CA2511907A1 (fr) 2003-01-06 2004-07-22 Wyeth Compositions et procede permettant de diagnostiquer et de traiter les cancers du colon
FR2855183B1 (fr) 2003-05-23 2005-08-12 Agronomique Inst Nat Rech Procede de clonage du rat par transfert nucleaire
PT1633767T (pt) 2003-06-02 2019-02-27 Univ Massachusetts Métodos e composições para controlar a eficácia do silenciamento de arn
CA2527958C (fr) 2003-06-02 2014-04-08 University Of Massachusetts Methodes et compositions en vue d'ameliorer l'efficacite et la specificicite de l'arni
US8409861B2 (en) 2003-08-08 2013-04-02 Sangamo Biosciences, Inc. Targeted deletion of cellular DNA sequences
US11311574B2 (en) 2003-08-08 2022-04-26 Sangamo Therapeutics, Inc. Methods and compositions for targeted cleavage and recombination
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US20120196370A1 (en) 2010-12-03 2012-08-02 Fyodor Urnov Methods and compositions for targeted genomic deletion
JP2007502119A (ja) 2003-08-14 2007-02-08 エクセリクシス， インク． βカテニン経路のモディファイヤーとしてのＵＰｓ及び使用方法
KR20060120652A (ko) 2003-10-07 2006-11-27 밀레니엄 파머슈티컬스 인코퍼레이티드 난소암의 확인, 평가, 예방 및 치료를 위한 핵산 분자 및단백질
EP1681988B1 (fr) 2003-11-12 2015-04-08 The Children's Hospital Medical Center Procede de diagnostic et de traitement de troubles pulmonaires
EP2386659B1 (fr) 2003-11-26 2014-01-15 Celera Corporation Polymorphismes génétiques associés à des maladies cardiovasculaires et réponse au médicament, procédés de détection et utilisations associées
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
CA2563064A1 (fr) 2004-04-22 2005-11-10 Kirin Beer Kabushiki Kaisha Animaux transgeniques et leurs utilisations
CA2852855C (fr) 2004-05-07 2016-07-05 Celera Corporation Polymorphismes genetiques associes a des techniques de detection de cirrhose du foie et utilisation de ces polymorphismes
JP2006081542A (ja) * 2004-08-18 2006-03-30 Institute Of Physical & Chemical Research クローン哺乳動物の作成方法
JP2008517931A (ja) 2004-10-22 2008-05-29 ダナ−ファーバー キャンサー インスティチュート，インコーポレイテッド 脂質関連疾患および障害を処置するための、ＰＧＣ−１βを調節するための方法および組成物
GB0426146D0 (en) 2004-11-29 2004-12-29 Bioxell Spa Therapeutic peptides and method
CN1274829C (zh) 2004-12-10 2006-09-13 四川大学华西医院 抗eb病毒所致肿瘤多肽及其应用与制备方法
JP5590697B2 (ja) 2005-03-11 2014-09-17 セレラ コーポレーション 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用
US20060286666A1 (en) * 2005-06-17 2006-12-21 Kang Ji Y Methods and apparatuses for culturing stem cell using biomaterial shell
US20070056050A1 (en) * 2005-06-29 2007-03-08 Clokie Cameron M L PRODUCTION OF BONE MORPHOGENIC PROTEINS (BMPs) IN TRANSGENIC MAMMALS
KR100733012B1 (ko) 2005-07-26 2007-06-28 재단법인서울대학교산학협력재단 복제된 개과 동물 및 이의 생산 방법
AU2006292827B2 (en) 2005-08-09 2013-02-14 Revivicor, Inc. Transgenic ungulates expressing CTLA4-IG and uses thereof
WO2007030820A2 (fr) 2005-09-09 2007-03-15 The Johns Hopkins University Manipulation de cellules t regulatrices et de fonctions dc en ciblant des genes de neuritine a l'aide d'agonistes et d'antagonistes d'anticorps
EP1926459B1 (fr) 2005-09-19 2015-01-07 Histogenics Corporation Matrice support de cellules dont la densite des pores et la porosite sont definies specifiquement de maniere uniforme verticalement et organisees de maniere non aleatoire, et procede de preparation de celle-ci
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US7695911B2 (en) 2005-10-26 2010-04-13 Celera Corporation Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
US8173860B2 (en) 2006-04-21 2012-05-08 Gtc Biotherapeutics, Inc. Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
CN101506235B (zh) 2006-09-01 2012-07-25 人类多细胞株治疗学公司 人或人源化免疫球蛋白在非人转基因动物中增强的表达
US7993833B2 (en) 2006-09-11 2011-08-09 Celera Corporation Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
EP2084297A4 (fr) 2006-10-20 2010-10-20 Celera Corp Polymorphismes génétiques associés à la thrombose veineuse, procédés pour les détecter et utilisations
KR101398220B1 (ko) 2006-10-30 2014-05-22 건국대학교 산학협력단 형질전환 배아 생성방법
WO2008085891A1 (fr) * 2007-01-05 2008-07-17 Worcester Polytechnic Institute Amélioration du clonage de cellules somatiques grâce à des facteurs associés au fuseau des ovocytes
KR100829426B1 (ko) 2007-01-17 2008-05-15 재단법인서울대학교산학협력재단 복제개의 생산 방법
US20080222745A1 (en) * 2007-03-07 2008-09-11 Utah State University Colcemid-Treatment of Oocytes to enhance Nuclear Transfer Cloning
KR100868245B1 (ko) 2007-05-29 2008-11-11 강원대학교산학협력단 데메콜친 처리에 의한 효율적인 복제 동물의 생산방법
US8663980B2 (en) 2007-10-26 2014-03-04 Janssen Biotech, Inc. Vectors, host cells, and methods of production and uses
US8039212B2 (en) 2007-11-05 2011-10-18 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
JP2011508600A (ja) 2008-01-04 2011-03-17 ソウル ナショナル ユニバーシティ インダストリー ファウンデーション 形質転換された複製犬の生産方法
US20090221620A1 (en) 2008-02-20 2009-09-03 Celera Corporation Gentic polymorphisms associated with stroke, methods of detection and uses thereof
EP2265730B1 (fr) 2008-03-12 2018-06-06 The Rockefeller University Procédés et compositions pour profil translationnel et phénotypage moléculaire
US8288094B2 (en) 2008-04-09 2012-10-16 Institut Pasteur APOBEC3 mediated DNA editing
EP2987498B1 (fr) 2008-05-02 2017-07-05 Laboratoire Français du Fractionnement et des Biotechnologies Traitement de saignement par un fibrinogène de faible demi-vie
US9238797B2 (en) 2008-07-07 2016-01-19 Takara Bio Inc. Method for production of pluripotent stem cell
WO2010006215A1 (fr) 2008-07-09 2010-01-14 Celera Corporation Polymorphismes génétiques associés à des maladies cardiovasculaires et procédés de détection et d'utilisation de ceux-ci
US9181315B2 (en) 2009-01-08 2015-11-10 Dana-Farber Cancer Institute, Inc. Compositions and methods for induced brown fat differentiation
US8722964B2 (en) 2009-04-23 2014-05-13 Transposagen Biopharmaceuticals, Inc. Genetically engineered or transgenic rats exhibiting a cancer phenotype due to a disruption of germline tumor suppressor genes
EP2267153A1 (fr) 2009-05-26 2010-12-29 Université Claude Bernard Lyon 1 Identification de la mutation du gène unc5c du récepteur de la nétrine-1 dans des cancers solides
EP2449112A1 (fr) 2009-07-01 2012-05-09 Transposagen Biopharmaceuticals, Inc. Modèles de rats génétiquement modifiés pour l'immunodéficience combinée sévère
US8558055B2 (en) 2009-07-24 2013-10-15 Transposagen Biopharmaceuticals, Inc. Genetically modified rat comprising a cytokine gene disruption and exhibiting a greater susceptibility to a cytokine-mediated autoimmune and/or inflammatory disease
EP2460016A2 (fr) 2009-07-30 2012-06-06 Transposagen Biopharmaceuticals, Inc. Modèles de rat génétiquement modifiés pour pharmacocinétique
US20110035816A1 (en) 2009-08-05 2011-02-10 Ostertag Eric M Genetically Modified Rat Models for Drug Metabolism
WO2011022634A2 (fr) 2009-08-20 2011-02-24 Transposagen Biopharmaceuticals, Inc. Modèles de rat génétiquement modifié pour le traitement de la douleur
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
EP2526424A2 (fr) 2010-01-22 2012-11-28 Dana-Farber Cancer Institute, Inc. Compositions, kits, et procédés d'identification, d'évaluation, de prévention, et de thérapie de troubles métaboliques
TWI518325B (zh) 2010-02-04 2016-01-21 自治醫科大學 對ａｌｋ抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
US10745467B2 (en) 2010-03-26 2020-08-18 The Trustees Of Dartmouth College VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders
AU2011230537C1 (en) 2010-03-26 2018-08-02 Trustees Of Dartmouth College Vista regulatory T cell mediator protein, vista binding agents and use thereof
US20150231215A1 (en) 2012-06-22 2015-08-20 Randolph J. Noelle VISTA Antagonist and Methods of Use
US8383793B2 (en) 2010-04-15 2013-02-26 St. Jude Children's Research Hospital Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors
US20110269735A1 (en) 2010-04-19 2011-11-03 Celera Corporation Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
US8956865B2 (en) 2010-08-11 2015-02-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods of growing an embryo to a blastocyst stage of development
US20120108651A1 (en) 2010-11-02 2012-05-03 Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
WO2012071393A2 (fr) 2010-11-23 2012-05-31 The New York Stem Cell Foundation Procédé de production de cellules souches pluripotentes
ES2680636T3 (es) 2011-02-14 2018-09-10 Revivicor Inc. Cerdos genéticamente modificados para xenotrasplante de xenoinjertos vascularizados y derivados de los mismos
WO2012129198A1 (fr) 2011-03-23 2012-09-27 Transposagen Biopharmaceuticals, Inc. Modèles de rat génétiquement modifiés pour l'étude de l'obésité et du diabète
US9820475B2 (en) 2011-05-16 2017-11-21 The Curators Of The University Of Missouri Porcine reproductive and respiratory syndrome virus resistant animals
US8969519B2 (en) 2011-09-13 2015-03-03 Dana-Farber Cancer Institute, Inc. Compositions and methods for brown fat induction and activity using FNDC5
CN102391989A (zh) * 2011-10-12 2012-03-28 扬州大学 转基因动物重组产物精确分析检验方法
US9550830B2 (en) 2012-02-15 2017-01-24 Novo Nordisk A/S Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
WO2013120554A1 (fr) 2012-02-15 2013-08-22 Novo Nordisk A/S Anticorps qui se lient à la protéine 1 de reconnaissance de peptidoglycane
CN104220456B (zh) 2012-02-15 2018-02-23 诺和诺德股份有限公司 结合并阻断髓样细胞表达的触发受体‑1 (trem‑1)的抗体
CN104619722B (zh) 2012-06-22 2022-10-04 达特茅斯大学理事会 新型vista-ig构建体和vista-ig用于治疗自身免疫性、过敏性和炎性疾病的用途
US9890215B2 (en) 2012-06-22 2018-02-13 King's College London Vista modulators for diagnosis and treatment of cancer
EP2892558B1 (fr) 2012-09-07 2019-04-10 The Trustees Of Dartmouth College Modulateurs vista de diagnostic et de traitement de cancer
US20140115728A1 (en) 2012-10-24 2014-04-24 A. Joseph Tector Double knockout (gt/cmah-ko) pigs, organs and tissues
JP2016508515A (ja) 2013-02-13 2016-03-22 ラボラトワール フランセ デュ フラクショヌマン エ デ ビオテクノロジーＬａｂｏｒａｔｏｉｒｅ Ｆｒａｎｃａｉｓ ｄｕ Ｆｒａｃｔｉｏｎｎｅｍｅｎｔ ｅｔ ｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ 高ガラクトシル化抗ＴＮＦ−α抗体およびその使用
EP2956003A2 (fr) 2013-02-13 2015-12-23 Laboratoire Français du Fractionnement et des Biotechnologies Protéines à glycosylation modifiée et leurs procédés de production
PL2993234T3 (pl) 2013-04-30 2019-04-30 Univ Konkuk Ind Coop Corp Wektor ukierunkowany na hydroksylazę kwasu cmp-acetyloneuraminowego, zwierzę transgeniczne do ksenoprzeszczepu z wprowadzonym wektorem i sposób ich wytwarzania
SI3712174T1 (sl) 2013-12-24 2022-06-30 Janssen Pharmaceutica Nv Protitelesa in delci proti VISTA
US11014987B2 (en) 2013-12-24 2021-05-25 Janssen Pharmaceutics Nv Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
AU2015206603B9 (en) 2014-01-14 2019-07-18 Dana-Farber Cancer Institute, Inc. Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms
MX389695B (es) 2014-06-11 2025-03-20 Kathy A Green Uso de agonistas y antagonistas vista para suprimir o aumentar la inmunidad humoral.
CN106536559B (zh) 2014-07-17 2021-04-27 诺和诺德股份有限公司 定点诱变trem-1抗体以降低黏度
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
MX2017007136A (es) 2014-12-05 2017-12-04 Immunext Inc Identificacion de vsig8 como el receptor vista putativo y su uso para producir moduladores vista/vsig8.
HRP20202034T1 (hr) 2014-12-09 2021-02-19 Regeneron Pharmaceuticals, Inc. Neljudske životinje s genom za humanizirani diferencijacijski biljeg cd274
CN104823921A (zh) * 2015-05-21 2015-08-12 蒙汉勤 一种用于人体烧伤皮肤移植及医学实验的小型香猪的饲养技术
DK3313882T3 (da) 2015-06-24 2020-05-11 Janssen Pharmaceutica Nv Anti-VISTA antistoffer og fragmenter
FR3038517B1 (fr) 2015-07-06 2020-02-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Utilisation de fragments fc modifies en immunotherapie
HUE066989T2 (hu) 2015-08-06 2024-09-28 Univ Missouri Sertés reprodukciós és légzõszervi szindróma vírusnak (PRRSV) ellenálló sertések és módosított CD163 génekkel rendelkezõ sejtek
US12194080B2 (en) 2015-10-29 2025-01-14 Dana-Farber Cancer Institute, Inc. Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids
JP2019509993A (ja) 2016-02-12 2019-04-11 ヤンセン ファーマシューティカ エヌブイ 抗ｖｉｓｔａ（ｂ７ｈ５）抗体
CR20180537A (es) 2016-04-15 2019-03-04 Immunext Inc Anticuerpos vista antihumanos y su uso
EP3654956A4 (fr) 2017-07-19 2021-04-28 Children's Medical Center Corporation Compositions et procédés pour traiter des maladies associées à un défaut d'empreinte
EA202092302A1 (ru) 2018-04-02 2021-02-02 Бристол-Майерс Сквибб Компани Антитела к trem-1 и их применения
CN112272516B (zh) 2018-04-06 2023-05-30 儿童医疗中心有限公司 用于体细胞重新编程和调整印记的组合物和方法
US11160260B2 (en) 2018-04-17 2021-11-02 The Curators Of The University Of Missouri Methods for protecting porcine fetuses from infection with porcine reproductive and respiratory syndrome virus (PRRSV)
US11548938B2 (en) 2018-08-21 2023-01-10 Quidel Corporation DbpA antibodies and uses thereof
CN115298213A (zh) 2019-12-19 2022-11-04 奎多公司 单克隆抗体融合
IL302983A (en) 2020-11-20 2023-07-01 Revivicor Inc Multi-transgenic pigs with growth hormone receptor knockout for xenotransplantation
CN118434281A (zh) 2021-09-20 2024-08-02 雷维维科公司 用于异种移植的包含十个基因修饰的多转基因猪

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR890003947B1 (ko) * 1985-12-11 1989-10-13 가부시기가이샤 시마즈세이사구쇼 세포융합장치
US5057420A (en) * 1987-06-05 1991-10-15 Granada Biosciences, Inc. Bovine nuclear transplantation
GB8714426D0 (en) * 1987-06-19 1987-07-22 Agricultural & Food Res Culture technique
CA2059199A1 (fr) * 1992-01-10 1993-07-11 Steen Willadsen Methode d'obtention d'oeufs de mammiferes, reconstitues et a maturite, par transplantation du noyau
GB2265909B (en) * 1992-04-01 1996-03-20 Inst Of Animal Physiology And Fusion of donor nucleus with recipient cytoplast in the absence of calcium ion
CA2145190A1 (fr) * 1992-09-22 1994-03-31 The Government Of The United States Of America As Represented By The Sec Retary, Department Of Health And Human Services Utilisation du taxol pour le traitement des lymphomes et du cancer du sein
CA2092258A1 (fr) * 1992-12-30 1994-07-01 Steven L. Stice Cellules de donneur synchronisees pour le transfert de noyaux chez les bovins
US5496720A (en) * 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
US5523226A (en) * 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
ATE255412T1 (de) * 1993-07-29 2003-12-15 Us Gov Health & Human Serv Verfahren zur behandlung atherosklerose oder restenose mit hilfe eines mikrotubulusstabilisators
WO1995016770A1 (fr) * 1993-12-17 1995-06-22 Abs Global, Inc. Cellules souches embryonnaires derivees de cellules du stade preblastocyste d'ongule et leur utilisation pour produire des ongules chimeres et transgeniques clones
EP0739412B1 (fr) * 1993-12-23 2002-02-27 Infigen, Inc. CELLULES d'ongules, SOUCHES D'EMBRYONS UTILISEES COMME DONNEUSES DE NOYAUX ET PROCEDES DE TRANSFERT DE NOYAUX POUR LA PRODUCTION D'ANIMAUX CHIMERIQUES ET TRANSGENIQUES
GB9417831D0 (en) * 1994-09-05 1994-10-26 Biotech & Biolog Scien Res Biological manipulation
US7307198B2 (en) * 1995-08-31 2007-12-11 Roslin Institute Ungulates produced by nuclear transfer of G1 cells
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US6215041B1 (en) * 1997-01-10 2001-04-10 University Of Mmassachusetts Cloning using donor nuclei from a non-quiesecent somatic cells
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
US6235969B1 (en) * 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
US6011197A (en) * 1997-03-06 2000-01-04 Infigen, Inc. Method of cloning bovines using reprogrammed non-embryonic bovine cells
AU8587598A (en) * 1997-07-26 1999-02-16 Wisconsin Alumni Research Foundation Trans-species nuclear transfer
US6225243B1 (en) * 1998-08-03 2001-05-01 Bba Nonwovens Simpsonville, Inc. Elastic nonwoven fabric prepared from bi-component filaments
AU6218899A (en) * 1998-10-12 2000-05-01 Geron Bio-Med Limited Porcine oocytes with improved developmental competence
US20050156424A1 (en) * 2000-02-29 2005-07-21 Thyssenkrupp Presta Ag Steering column and manufacturing method thereof

Also Published As

Publication number Publication date
GB2318578A (en) 1998-04-29
EP0849990B1 (fr) 2001-02-14
AU716956B2 (en) 2000-03-09
CA2229568A1 (fr) 1997-03-06
CN1769432A (zh) 2006-05-10
NO980845D0 (no) 1998-02-27
US6147276A (en) 2000-11-14
SG75155A1 (en) 2000-09-19
US7355094B2 (en) 2008-04-08
DE69611793D1 (de) 2001-03-22
US7514258B2 (en) 2009-04-07
US20060156424A1 (en) 2006-07-13
JP2006217913A (ja) 2006-08-24
JP4081613B2 (ja) 2008-04-30
PL325331A1 (en) 1998-07-20
JP2000506722A (ja) 2000-06-06
CN1769431A (zh) 2006-05-10
KR100533476B1 (ko) 2006-04-21
AU6831096A (en) 1997-03-19
HK1090089A1 (zh) 2006-12-15
WO1997007669A1 (fr) 1997-03-06
CN1230533C (zh) 2005-12-07
US20070033664A1 (en) 2007-02-08
NZ337311A (en) 2008-05-30
EP0849990A1 (fr) 1998-07-01
DK0849990T3 (da) 2001-04-17
CA2229568C (fr) 2011-11-22
BR9610034A (pt) 1999-12-21
KR20070047848A (ko) 2007-05-07
BR9610034B1 (pt) 2011-03-09
HK1004938A1 (en) 1998-12-18
EP0930009A1 (fr) 1999-07-21
US7232938B2 (en) 2007-06-19
ATE199115T1 (de) 2001-02-15
US20050010966A1 (en) 2005-01-13
HUP9900234A2 (hu) 1999-05-28
US20070028313A1 (en) 2007-02-01
CN1202084A (zh) 1998-12-16
KR19990044148A (ko) 1999-06-25
AU716956C (en) 2002-03-28
ES2155197T3 (es) 2001-05-01
KR100793220B1 (ko) 2008-01-10
NZ316149A (en) 1999-10-28
NZ334288A (en) 2000-06-23
GB9802915D0 (en) 1998-04-08
IL123298A0 (en) 1998-09-24
ZA967390B (en) 1998-03-02
DE69611793T2 (de) 2001-09-20
CZ60898A3 (cs) 1998-07-15
GB2318578B (en) 2000-01-19
EP1005789A2 (fr) 2000-06-07
KR20050088163A (ko) 2005-09-01
NO980845L (no) 1998-04-29
KR20060053008A (ko) 2006-05-19
EP1005789A3 (fr) 2005-03-02
HUP9900234A3 (en) 2000-03-28
GB9517780D0 (en) 1995-11-01
CN100422317C (zh) 2008-10-01

Similar Documents

Publication Publication Date Title
GB2318578B (en) Quiescent cell populations for nuclear transfer
IL100040A0 (en) Nucleic acid amplification by two-enzyme,self-sustained sequence replication
IL108144A0 (en) Non-reducing saccharideforming enzyme, its preparation and uses
AU3628793A (en) Platform for recovering solar energy
DE3167468D1 (en) Method for preparing 2,5-diketo-d-gluconic acid and microorganisms for carrying out the method
EP0311385A3 (en) Optically active hydroxybenzylamine derivative, optically active amine-boron compound containing said derivative, and process for producing optically active compound by using said compound
GB2331751B (en) Quiescent cell populations for nuclear transfer
GB9016114D0 (en) A method of,and system for,altering the rate at which digital circuitry operates
GB2207711B (en) Method for harnessing tidal energy.
OA08721A (en) Pesticidal method using 2-phenylimidazole derivatives.
GB9325804D0 (en) An aid to recovery from disease caused by bacteria,viruses and malignant cells
FI880681A7 (fi) Menetelmä perunan lisääntymistehokkuuden kohottamiseksi in vitro.
HU9402188D0 (en) Method for making universal donor cells
FR2607458B1 (fr) Dispositif individuel destine au transport de bacs en particulier de bacs a vendanges
HK1019394B (en) Quiescent cell populations for nuclear transfer
HK1019394A1 (en) Quiescent cell populations for nuclear transfer
AU2003271356C1 (en) Quiescent cell population for nuclear transfer
YU67083A (en) Device for carrying out a method of combusting of waste parts of corn,particularly straw
GB2321840B (en) Recovery of cryopreserved plant cells
DZ1948A1 (fr) Système de récupération et d'alimentation énergétique, système hydro-électrique.
JPS5751604A (en) Disposal plant for refuse, etc.
ZA856226B (en) Method for recovering purified growth hormones from genetically engineered microorganisms
AR241958A1 (es) Central de fuerza motriz de energia solar
PL310367A1 (en) Apparatus for separating and thickening mechanical suspensions carried by water, especially in hydraulic slag and ash transport systems at power and/orheat generating plants
IT1157790B (it) Sistema integrato modulare costituito da un convertitore accumulatore termico per reattori termonucleari a fusione